Literature DB >> 19504007

Iloprost, a prostacyclin (PGI2) analogue, reduces liver injury in hepatic ischemia-reperfusion in rats.

Ercan Gedik1, Sadullah Girgin, Basra Deniz Obay, Hayrettin Ozturk, Hulya Ozturk, Huseyin Buyukbayram.   

Abstract

PURPOSE: To evaluate the effects of iloprost a prostacyclin analogue on the hepatic IR injury in rats.
METHODS: Forty male Sprague-Dawley rats (250-300 g) were divided into four groups each containing 10 rats;(1)--controls: data from unmanipulated animals; (2) sham group: rats subjected to the surgical procedure, except for liver I/R, and given saline; (3) I/R group: rats that underwent liver ischemia for 45 min followed by reperfusion for 45 min; (4) IR/ Iloprost group: rats pretreated with iloprost (10 microg kg-1, i.v). Liver tissues were taken to determine SOD, CAT, GSH, and MDA levels and for biochemical and histological evaluation.
RESULTS: The plasma ALT and AST levels were increased in group 3 than in group 4. MDA values and the liver injury score decreased, while the SOD, CAT, and GSH values increased in group 4 compared to group 3. In group 3, hepatocytes were swollen with marked vacuolization. In group 4, there were regular sinusoidal structures with normal morphology without any signs of congestion.
CONCLUSION: We demonstrated hepatoprotective effects of iloprost against severe ischemia and reperfusion injury in rat liver.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504007     DOI: 10.1590/s0102-86502009000300012

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  4 in total

1.  Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats.

Authors:  Yasin Ay; Ibrahim Kara; Cemalettin Aydin; Nuray Kahraman Ay; Melike Elif Teker; Serkan Senol; Bekir Inan; Halil Basel; Omer Uysal; Rahmi Zeybek
Journal:  Int J Clin Exp Med       Date:  2013-08-01

2.  The effect of Liv-52 on liver ischemia reperfusion damage in rats.

Authors:  Orhan Cimen; Hüseyin Eken; Ferda Keskin Cimen; Arif Burak Cekic; Nezahat Kurt; Asli Ozbek Bilgin; Bahadir Suleyman; Halis Suleyman; Renad Mammadov; Kamil Pehlivanoglu; Eray Kurnaz
Journal:  BMC Pharmacol Toxicol       Date:  2020-01-03       Impact factor: 2.483

Review 3.  Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury.

Authors:  Xin-Li Mao; Yue Cai; Ya-Hong Chen; Yi Wang; Xiu-Xiu Jiang; Li-Ping Ye; Shao-Wei Li
Journal:  Front Med (Lausanne)       Date:  2022-01-04

4.  Study on the Mechanism of Reducing Hepatotoxicity of Water-Grinding Realgar by Metabolomics, Morphology, and Chemical Analysis.

Authors:  Ting Han; Hui Zhang; Wenjuan Xu; Chunshuai Li; Min Wang; Yuying Bai; Linlin Yang; Shuyan Zhang; Zhe Jia; Xinfang Xu; Chongjun Zhao; Feng Wei; Xiangri Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-14       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.